Table 1 |
||||
|
Age distribution of patients with clinically diagnosed malaria in Namaacha and Matutuine districts, southern Mozambique (n = 31,438) |
||||
| AS+SP |
artemether-lumefantrine |
|||
|
|
||||
| Age |
Observed n (percentage) |
Age |
Estimated percentage |
Basis for calculation* |
|
|
||||
| 1–6 years |
8,882 (28.3%) |
1–5 years |
23.6% |
As for AS+SP, less 4.7% to cater for 6 year olds |
| 7–13 years |
4,814 (15.3%) |
6–8 years |
9.1% |
As for AS+SP, plus 4.7% to include 6 year olds, minus 10.9% to exclude 9–13 year olds |
| 14+ years |
17,742 (56.4%) |
9–12 years |
8.7% |
100% minus the other age categories' % |
| 13+ years |
58.6% |
As for AS+SP, plus 2.2% to include 13 year olds |
||
|
|
||||
| 100% |
100% |
|||
|
|
||||
|
* assuming even age distribution within each age category. |
||||
|
Zikusooka et al. Malaria Journal 2008 7:176 doi:10.1186/1475-2875-7-176 |
||||
